以药剂师为主导的护理降低了糖尿病癌症患者的血糖,在几个月内加强了控制。 Pharmacist-led care lowered blood sugar in cancer patients with diabetes, improving control within months.

由药剂师领导的糖尿病护理大大改善了糖尿病或高血糖癌症患者的血糖控制, 平均HbA1c水平在几个月内下降约一个百分点。 A new study from UC San Diego published October 30, 2025, finds that pharmacist-led diabetes care significantly improved blood sugar control in cancer patients with diabetes or high blood sugar, with average HbA1c levels dropping by about one percentage point within months. 这项研究以药剂师诊所79名成年人提供的数据为基础,表明病人花在健康的葡萄糖范围的时间较多,波动较少,在个人化药物管理、教育和经常通过面对面和远程保健访问进行后续跟踪的帮助下,患者得到的帮助是个人化药物管理、教育以及经常跟踪。 The research, based on data from 79 adults in a pharmacist-staffed clinic, showed patients spent more time in a healthy glucose range and experienced fewer fluctuations, aided by personalized medication management, education, and frequent follow-ups via in-person and telehealth visits. 研究结果突出表明,将药剂师纳入肿瘤护理对于解决治疗经常破坏血糖控制的病人的复杂需要具有价值,尽管研究人员指出,这项研究是回顾性的,要求进一步调查长期结果。 The findings highlight the value of integrating pharmacists into oncology care to address the complex needs of patients whose treatments often disrupt blood sugar control, though researchers note the study was retrospective and call for further investigation into long-term outcomes.